← back to search

Guochao Liao

Guangzhou University of Chinese Medicine · CN
🔎 Find collaborators in Immunology · Molecular Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Immunology · Molecular Biology
Research interest
Research interests include Chemistry, Computational biology, Cytotoxicity, Adjuvant, Conjugate, and Immune system.
h-index
citations
2,283
works
59
NIH funding
primary concept
email

Recent publications

Biointerface-engineered trabecular scaffolds integrating chitosan/icariin self-assembly and mild photothermal regulation for enhanced osteogenesis
Colloids and Surfaces B Biointerfaces 2026cited by 0position: middledoi
Ganglioside GM3 and Lipid A Mimetic Conjugate Combined with EcMPLA and QS-21 as a Potential Vaccine Candidate for Cutaneous Melanoma Immunotherapy
Journal of Medicinal Chemistry 2026cited by 0position: lastdoi
Molecularly integrated dynamic chitosan network with topology-adaptive glucose/ROS responsiveness for coupled drug release and immunoregulation
Chemical Engineering Journal 2026cited by 0position: middledoi
Optimization, Immunological Evaluation, and Combination Study of Mincle-Dependent Self-Adjuvanted Anti-Tn Cancer Vaccines with an External Adjuvant
Journal of Medicinal Chemistry 2025cited by 2position: lastdoi
A customized immunomodulator reinforces the T cell-mediated immunological cascade for cancer therapy
Chemical Engineering Journal 2025cited by 0position: middledoi
Nanoclay-Triggered In Situ Self-Gelling Yam Microparticles via Coagulation Activation for Robust Wet Tissue Adhesion and Instant Hemostasis
ACS Applied Materials & Interfaces 2025cited by 0position: middledoi
Mitochondria-targeted carrier-free nanoparticles based on dihydroartemisinin against hepatocellular carcinoma
Chinese Chemical Letters 2024cited by 14position: lastdoi
Fully Synthetic TF-Based Self-Adjuvanting Vaccine Simultaneously Triggers iNKT Cells and Mincle and Protects Mice against Tumor Development
Journal of Medicinal Chemistry 2024cited by 7position: lastdoi
Design, Synthesis, and Bioactivity Evaluation of a TF-Based Cancer Vaccine Candidate Using Lipid A Mimetics As a Built-In Adjuvant
Journal of Medicinal Chemistry 2024cited by 4position: lastdoi
Structure-based optimization of isoaurostatin as novel PDE4 inhibitors with anti-fibrotic effects
Chinese Chemical Letters 2024cited by 3position: middledoi
Design, synthesis and biological evaluation of the positional isomers of the galactose conjugates able to target hepatocellular carcinoma cells via ASGPR-mediated cellular uptake and cytotoxicity
European Journal of Medicinal Chemistry 2023cited by 25position: middledoi
Discovery of new tetrahydroisoquinolines as potent and selective LSD1 inhibitors for the treatment of MLL-rearranged leukemia
European Journal of Medicinal Chemistry 2023cited by 3position: lastdoi
Assessment of Purity, Stability, and Pharmacokinetics of NGP-1, a Novel Prodrug of GS441254 with Potential Anti-SARS-CoV-2 Activity, Using Liquid Chromatography
Molecules 2023cited by 2position: middledoi
Fully synthetic Tn-based three-component cancer vaccine using covalently linked TLR4 ligand MPLA and iNKT cell agonist KRN-7000 as built-in adjuvant effectively protects mice from tumor development
Acta Pharmaceutica Sinica B 2022cited by 33position: lastdoi
MUC1 vaccines using β-cyclodextrin grafted chitosan (CS-g-CD) as carrier via host-guest interaction elicit robust immune responses
Chinese Chemical Letters 2022cited by 18position: middledoi
Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants
Virology Journal 2022cited by 14position: firstdoi
Design, synthesis and immunological evaluation of monophosphoryl lipid A derivatives as adjuvants for a RBD-hFc based SARS-CoV-2 vaccine
RSC Medicinal Chemistry 2022cited by 5position: middledoi
Human Fc-Conjugated Receptor Binding Domain-Based Recombinant Subunit Vaccines with Short Linker Induce Potent Neutralizing Antibodies against Multiple SARS-CoV-2 Variants
Vaccines 2022cited by 4position: middledoi
Discovery of higenamine as a potent, selective and cellular active natural LSD1 inhibitor for MLL-rearranged leukemia therapy
Bioorganic Chemistry 2021cited by 23position: lastdoi
Fully synthetic Mincle-dependent self-adjuvanting cancer vaccines elicit robust humoral and T cell-dependent immune responses and protect mice from tumor development
Chemical Science 2021cited by 21position: lastdoi
Full synthesis and bioactivity evaluation of Tn-RC-529 derivative conjugates as self-adjuvanting cancer vaccines
Chinese Chemical Letters 2021cited by 14position: lastdoi
Ras inhibitor farnesylthiosalicylic acid conjugated with IR783 dye exhibits improved tumor-targeting and altered anti-breast cancer mechanisms in mice
Acta Pharmacologica Sinica 2021cited by 8position: middledoi
β-1,2-Mannan-based glycoconjugates as potential antifungal vaccines
Chinese Chemical Letters 2021cited by 6position: middledoi
Single-shot rAAV5-based Vaccine Provides Long-term Protective Immunity against SARS-CoV-2 and Its Variants
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 1position: firstdoi
Synthesis and Biological Activities of Diosgenin-Triazole Conjugates with a 1,3-Dipolar Cycloaddition Reaction
Chemistry of Natural Compounds 2021cited by 0position: middledoi
Natural products as LSD1 inhibitors for cancer therapy
Acta Pharmaceutica Sinica B 2020cited by 116position: middledoi
Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
Acta Pharmaceutica Sinica B 2020cited by 98position: middledoi
Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed Cell Death-1/Programmed Cell Death–Ligand 1 Interaction as Potential Anticancer Agents
Journal of Medicinal Chemistry 2020cited by 80position: middledoi
Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection
Chemical Communications 2020cited by 39position: lastdoi
Induction of lipid droplets in THP-1 macrophages by multi-walled carbon nanotubes in a diameter-dependent manner: A transcriptomic study
Toxicology Letters 2020cited by 31position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zhongqiu Liu · Guangzhou University of Chinese Medicine20 papers (2018–2026)Xiang Luo · Jiangsu University10 papers (2021–2025)Deying Yang · Guangzhou University of Chinese Medicine9 papers (2018–2026)Yuan Fang · West China Hospital of Sichuan University8 papers (2018–2023)Lingqiang Gao · Guangzhou University of Chinese Medicine7 papers (2020–2026)Zhiqiang Yu · Guangzhou University of Chinese Medicine6 papers (2017–2024)Bin Yu · Guangzhou University6 papers (2018–2020)Xiaoxiao Qi · Henan University of Technology5 papers (2020–2025)Yi Cao · Guangzhou University of Chinese Medicine5 papers (2018–2020)Wenbo Ming · Guangzhou University of Chinese Medicine4 papers (2024–2026)Qinghai Lian · Guangzhou University of Chinese Medicine4 papers (2020–2022)Zhongwu Guo · Shandong University3 papers (2017–2019)Peng Wu · Massachusetts Institute of Technology3 papers (2018–2020)Chao Yang · National University of Singapore3 papers (2020–2023)Qiuye Wu · Second Military Medical University3 papers (2019–2021)Pinghua Sun · Guangzhou University of Chinese Medicine3 papers (2017–2019)Qingjie Zhao · Second Military Medical University3 papers (2019–2021)Jun Liao · Southwestern Medical Center3 papers (2019–2021)Xiaohui Li · Third Affiliated Hospital of Zhengzhou University3 papers (2022–2024)Wenwei Li · Tongde Hospital of Zhejiang Province3 papers (2018–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Immunology · Molecular Biology →